Collaborative Medicinal Development
Sausalito
About Collaborative Medicinal Development
Collaborative Medicinal Development is a privately-held biopharmaceutical company developing innovative therapies for neurodegenerative diseases. The Company's lead drug, CuATSM, was licensed from the University of Melbourne and entered clinical trials in ALS and Parkinson's disease in 2017.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $717.2K
- Last round: Grant (Apr 2019)
- Website: colmeddev.com
- Phone: 1 (415) 444-9607
Industries & Categories
Biopharma, Health Care, Medical
Canonical: https://fsome.com/organization/collaborative-medicinal-development-163966 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.